These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34546648)

  • 21. Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration.
    Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration
    Lancet HIV; 2019 Feb; 6(2):e105-e115. PubMed ID: 30723008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do not forget the children: a model-based analysis on the potential impact of COVID-19-associated interruptions in paediatric HIV prevention and care.
    Flanagan CF; McCann N; Stover J; Freedberg KA; Ciaranello AL
    J Int AIDS Soc; 2022 Jan; 25(1):e25864. PubMed ID: 35048515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.
    Siedner MJ; Ng CK; Bassett IV; Katz IT; Bangsberg DR; Tsai AC
    Clin Infect Dis; 2015 Apr; 60(7):1120-7. PubMed ID: 25516189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
    Stover J; Glaubius R; Teng Y; Kelly S; Brown T; Hallett TB; Revill P; Bärnighausen T; Phillips AN; Fontaine C; Frescura L; Izazola-Licea JA; Semini I; Godfrey-Faussett P; De Lay PR; Benzaken AS; Ghys PD
    PLoS Med; 2021 Oct; 18(10):e1003831. PubMed ID: 34662333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methods and Assumptions for Estimating Key HIV Indicators in the UNAIDS Annual Estimates Process.
    Stover J; Glaubius R
    J Acquir Immune Defic Syndr; 2024 Jan; 95(1S):e5-e12. PubMed ID: 38180735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 90-90-90 by 2020? Estimation and projection of the adult HIV epidemic and ART programme in Zimbabwe - 2017 to 2020.
    Bansi-Matharu L; Cambiano V; Apollo T; Yekeye R; Dirawo J; Musemburi S; Davey C; Napierala S; Fearon E; Mpofu A; Mugurungi O; Hargreaves JR; Cowan FM; Phillips AN
    J Int AIDS Soc; 2018 Nov; 21(11):e25205. PubMed ID: 30465689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.
    Rajasingham R; Smith RM; Park BJ; Jarvis JN; Govender NP; Chiller TM; Denning DW; Loyse A; Boulware DR
    Lancet Infect Dis; 2017 Aug; 17(8):873-881. PubMed ID: 28483415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using the TIME model in Spectrum to estimate tuberculosis-HIV incidence and mortality.
    Pretorius C; Glaziou P; Dodd PJ; White R; Houben R
    AIDS; 2014 Nov; 28 Suppl 4(4):S477-87. PubMed ID: 25406751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
    Schomaker M; Egger M; Ndirangu J; Phiri S; Moultrie H; Technau K; Cox V; Giddy J; Chimbetete C; Wood R; Gsponer T; Bolton Moore C; Rabie H; Eley B; Muhe L; Penazzato M; Essajee S; Keiser O; Davies MA;
    PLoS Med; 2013 Nov; 10(11):e1001555. PubMed ID: 24260029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
    Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
    PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in antiretroviral therapy guidelines: implications for public health policy and public purses.
    Hamilton A; Garcia-Calleja JM; Vitoria M; Gilks C; Souteyrand Y; De Cock K; Crowley S
    Sex Transm Infect; 2010 Oct; 86(5):388-90. PubMed ID: 20876757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating the potential impact of COVID-19-related disruptions on HIV incidence and mortality among men who have sex with men in the United States: a modelling study.
    Mitchell KM; Dimitrov D; Silhol R; Geidelberg L; Moore M; Liu A; Beyrer C; Mayer KH; Baral S; Boily MC
    medRxiv; 2020 Nov; ():. PubMed ID: 33173893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age patterns and sex ratios of adult mortality in countries with high HIV prevalence.
    Masquelier B; Eaton JW; Gerland P; Pelletier F; Mutai KK
    AIDS; 2017 Apr; 31 Suppl 1():S77-S85. PubMed ID: 28296803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old.
    Siegfried N; Davies MA; Penazzato M; Muhe LM; Egger M
    Cochrane Database Syst Rev; 2013 Oct; 10(10):CD010309. PubMed ID: 24114324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in demographic and clinical characteristics and initiation of antiretroviral therapy among adult patients enrolling in HIV care in the Central Africa International epidemiology Database to Evaluate AIDS (CA-IeDEA) 2004 to 2018.
    Adedimeji AA; Hoover DR; Shi Q; Kim HY; Brazier E; Ross J; Murenzi G; Twizere C; Lelo P; Nsonde D; Ajeh R; Dzudie A; Nash D; Yotebieng M; Anastos K;
    J Int AIDS Soc; 2021 Jun; 24(6):e25672. PubMed ID: 34152663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adolescent HIV treatment in South Africa's national HIV programme: a retrospective cohort study.
    Maskew M; Bor J; MacLeod W; Carmona S; Sherman GG; Fox MP
    Lancet HIV; 2019 Nov; 6(11):e760-e768. PubMed ID: 31585836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis.
    Dorward J; Khubone T; Gate K; Ngobese H; Sookrajh Y; Mkhize S; Jeewa A; Bottomley C; Lewis L; Baisley K; Butler CC; Gxagxisa N; Garrett N
    Lancet HIV; 2021 Mar; 8(3):e158-e165. PubMed ID: 33549166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012-2019.
    Chammartin F; Dao Ostinelli CH; Anastos K; Jaquet A; Brazier E; Brown S; Dabis F; Davies MA; Duda SN; Malateste K; Nash D; Wools-Kaloustian K; von Groote PM; Egger M
    BMJ Open; 2020 May; 10(5):e035246. PubMed ID: 32414825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empirical validation of the UNAIDS Spectrum model for subnational HIV estimates: case-study of children and adults in Manicaland, Zimbabwe.
    Silhol R; Gregson S; Nyamukapa C; Mhangara M; Dzangare J; Gonese E; Eaton JW; Case KK; Mahy M; Stover J; Mugurungi O
    AIDS; 2017 Apr; 31 Suppl 1(Suppl 1):S41-S50. PubMed ID: 28296799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.